Training Program for Regulatory Project Managers; Information Available to Industry

Thu, Dec 29 2005 11:00:00 GMT

The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) is announcing the continuation of the Regulatory Project Management Site Tours and Regulatory Interaction Program (the Site Tours Program). The purpose of this notice is to invite pharmaceutical companies interested in participating in this program to contact CDER.

Statement of Organization, Functions, and Delegations of Authority

Thu, Dec 29 2005 11:00:00 GMT

Part F of the Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services, Centers for Medicare & Medicaid Services (CMS), (Federal Register, Vol. 62, No. 85, pp. 2412024126, dated Friday, May 2, 1997, as amended thereafter) is being republished to reflect the current organizational structure of CMS in relation to meeting the Department's goal of having no more than four management levels in the Agency and to also exercise leadership in implementing the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA).

Part F is described below:

Section F.10. (Organization) reads as follows: 1. Office of External Affairs (FAC)
2. Center for Beneficiary Choices (FAE)
3. Office of Legislation (FAF)
4. Center for Medicare Management (FAH)
5. Office of Equal Opportunity and Civil Rights (FAJ)
6. Office of Research, Development, and Information (FAK)
7. Office of Clinical Standards and Quality (FAM)
8. Office of the Act

The Federal Register

Training Program for Regulatory Project Managers; Information Available to Industry

Statement of Organization, Functions, and Delegations of Authority